Physician profile
Benjamin Remo
NPI 1376785717
$19,859.69
in general payments reported to CMS, 2019-2025
19 companies · $8,402 in 2025
The $8,402 reported for 2025 was more than what 77% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,044 · 2020: $664 · 2021: $410 · 2022: $552 · 2023: $4,740 · 2024: $3,049 · 2025: $8,402.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,932 · Food and Beverage: $5,259 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,931.55 |
| Food and Beverage | $5,258.84 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $10,219.00 | 2019-2025 | Watchman Access System, Emblem Mri S-Icd, Lux-Dx Insertable Cardiac Monitor |
| Abbott Laboratories | $3,275.11 | 2019-2025 | Aveir, Assurity, Jot Dx |
| Medtronic, INC. | $3,162.03 | 2021-2025 | Micra, Cobalt Dr Mri Surescan, Linq II |
| Medtronic Vascular, INC. | $1,865.90 | 2019-2020 | |
| Biosense Webster, INC. | $534.07 | 2023-2024 | Carto 3 |
| Medical Device Business Services, INC. | $249.01 | 2022 | |
| Irhythm Technologies, INC. | $133.27 | 2020-2024 | Zio Xt Patch, Zio Monitor |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $105.16 | 2022-2025 | Lifevest |
| Cvrx, INC. | $76.66 | 2023 | Barostim Neo System |
| E.R. Squibb & Sons, L.L.C. | $42.76 | 2021-2024 | Eliquis |
| Cardiva Medical, INC. | $40.46 | 2024-2025 | Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Vvcs 6-12f |
| Pfizer INC. | $37.89 | 2019 | |
| Baxter Healthcare | $18.68 | 2025 | Perclot |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.63 | 2022 | |
| Amgen INC. | $18.36 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elutia, INC. | $17.27 | 2021 | |
| Itamar Medical INC | $16.56 | 2023 | Watchpatone |
| Novartis Pharmaceuticals Corporation | $16.37 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $12.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Remo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.